FisherVista

LIG Assets, Inc. is working on a technical report under SEC Regulation S-K Subpart 1300 to update the valuation of its calcium carbonate mining assets in Marianna, Florida, which were previously appraised at $400 million in 2009, aiming to reflect substantial market changes and enhance transparency.

BluSky AI Inc. announced a Regulation A+ offering to raise funds for expanding its modular AI Factory footprint and Neocloud compute capacity across the United States, allowing individual and accredited investors to participate with a minimum investment of $1,000.

Aditxt (NASDAQ: ADTX) will implement a 1-for-27 reverse stock split on May 18, 2026, to meet Nasdaq’s minimum bid price requirement, reducing outstanding shares from 13.8 million to about 510,123.

SPARC AI Inc. is featured in an AINewsWire editorial discussing its software-only platform that enables drones to navigate and target without GPS, addressing critical defense needs in contested electronic warfare environments.

MindBio Therapeutics Corp. is developing an AI-driven voice analysis platform to detect drug and alcohol impairment from brief speech recordings, addressing growing demand for noninvasive, scalable intoxication detection in healthcare, workplace safety, and public health.

CNS Pharmaceuticals (NASDAQ: CNSP) reported first-quarter 2026 financial results and detailed a strategic transformation toward acquiring clinical-stage neurology and oncology assets, supported by a $22.5 million private placement to fund operations and potential acquisitions.

Kairos Pharma receives the 2026 GHP Magazine Healthcare & Pharmaceutical Award for its work in developing cancer therapies that overcome drug resistance, highlighting its lead candidate ENV-105 currently in clinical trials.

SureNano Science Ltd. announced its featured BioMedWire editorial on GEP-44, a novel triple agonist peptide from its subsidiary GlucaPharm Inc., aiming to improve efficacy, tolerability, and delivery flexibility in obesity and type 2 diabetes care.

NextPlat Corp posts record gross margins and reduced losses in Q1 2026 as turnaround efforts gain traction, targeting positive operating income by H2.

American Fusion Inc. updates on strategic D.C. engagements for its Texatron Fusion Engine in defense and energy, while progressing toward OTCQB listing and 5MW pre-production unit.

Tonix Pharmaceuticals will present a poster at ISPOR 2026 analyzing real-world fibromyalgia treatment patterns following the FDA approval of TONMYA, marking the first new therapy for the condition in over 15 years.

G Mining Ventures Corp. posted record net income of $80.4 million and free cash flow of $56.2 million in Q1 2026, driven by strong margins at its Tocantinzinho mine and higher gold prices, while maintaining full-year production guidance of 160,000–190,000 ounces.

HeartBeam Inc. reported first-quarter 2026 operational and financial results, highlighting initial commercial partnerships, progress in cardiac detection initiatives, and a $11.5 million public offering, with a net loss improvement to $4.7 million.

Nevada Organic Phosphate Inc. plans a non-brokered private placement of up to $2 million to fund its phase two drill program at the Murdock Property, advancing what is believed to be the only known large-scale organic sedimentary phosphate project in North America.

The culinary offerings in the Middle Keys, from waterfront restaurants to fresh seafood markets, are increasingly influencing high-end homebuyers' decisions, according to the top-selling real estate team on Duck Key.

Alphabet plans to issue yen-denominated bonds to fund its AI ambitions, highlighting the escalating capital needs of major tech companies in the AI race.

New preclinical research suggests that men with lower testosterone levels may have shorter survival times when diagnosed with glioblastoma, offering potential implications for treatment approaches.

China is implementing new regulations to formalize electric vehicle battery recycling, requiring end-of-life batteries to go through authorized channels to address safety and environmental concerns from informal operations that currently handle most retired batteries.

Oncotelic Therapeutics' intranasal delivery platform that bypasses the blood-brain barrier is featured in a BioMedWire editorial, underscoring its potential impact on neurological treatments and biodefense.

Shareholders of Trilogy Metals Inc. approved all proposals at the annual meeting, including director elections and executive compensation, with 62.84% of eligible shares represented.